跳至主要内容
临床试验/CTRI/2018/09/015808
CTRI/2018/09/015808已完成2 期

Pharmaceutico-Analytical study and clinical evaluation of Vanga preparations in Diabetes Mellitus (type-II)

ational Institute of Ayurveda Jaipur0 个研究点目标入组 30 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Presence of sign and symptoms of Madhumeha described in Ayurveda classics
  • Confirmed cases of DM type II on the basis of laboratory investigations and observed sign and symptoms
  • Patients having F.B.S. level ranges between 100 â?? 160 mg/dl and P.P.B.S. between 160 â?? 200 mg/dl will be selected for the study

排除标准

  • Patient with type I Diabetes mellitus.
  • Patients who are insulin dependent.
  • Patients of Gestational Diabetes.
  • Patient having Type-II DM with any other serious systemic disease.
  • Nephropathy and other secondary complications
  • Diabetes Mellitus produced due to other illnesses like Acromegaly, Cushingâ??s syndrome, pancreatic disorders etc

研究者

发起方
ational Institute of Ayurveda Jaipur

相似试验